DACLATASVIR vs DACOMITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DACLATASVIR vs DACOMITINIB: Safety Overview
| Metric | DACLATASVIR | DACOMITINIB |
|---|---|---|
| Total FAERS Reports | 5,602 | 682 |
| Deaths Reported | 581 | 325 |
| Death Rate | 10.4% | 47.7% |
| Hospitalizations | 1,637 | 168 |
| Average Patient Age | 58.1 yrs | 64.0 yrs |
| % Female Patients | 39.7% | 52.0% |
| FDA Approval Date | Apr 13, 2016 | Sep 27, 2018 |
| Manufacturer | N/A | Pfizer Laboratories Div Pfizer Inc |
| Route | N/A | ORAL |
| Marketing Status | Discontinued | Prescription |